Drug Information

Drug General Information
Drug ID
D0MV0T
Former ID
DNC013100
Drug Name
2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-imine
Drug Type
Small molecular drug
Indication Discovery agent Investigative [528402]
Formula
C11H11N3
Canonical SMILES
C1CC2=NC3=CC=CC=C3C(=N)N2C1
InChI
1S/C11H11N3/c12-11-8-4-1-2-5-9(8)13-10-6-3-7-14(10)11/h1-2,4-5,12H,3,6-7H2
InChIKey
AOSPPBURKIEYRC-UHFFFAOYSA-N
PubChem Compound ID
21094663
Target and Pathway
Target(s) Acetylcholinesterase Target Info Inhibitor [528402]
Cholinesterase Target Info Inhibitor [528402]
KEGG Pathway Glycerophospholipid metabolism
Cholinergic synapse
PANTHER Pathway Muscarinic acetylcholine receptor 1 and 3 signaling pathway
Muscarinic acetylcholine receptor 2 and 4 signaling pathway
Nicotinic acetylcholine receptor signaling pathwayP00042:Muscarinic acetylcholine receptor 1 and 3 signaling pathway
Nicotinic acetylcholine receptor signaling pathway
Pathway Interaction Database ATF-2 transcription factor network
PathWhiz Pathway Phospholipid Biosynthesis
WikiPathways Monoamine Transport
Biogenic Amine Synthesis
Acetylcholine Synthesis
Integrated Pancreatic Cancer PathwayWP229:Irinotecan Pathway
References
Ref 528402J Med Chem. 2006 Sep 7;49(18):5411-3.Homobivalent quinazolinimines as novel nanomolar inhibitors of cholinesterases with dirigible selectivity toward butyrylcholinesterase.
Ref 528402J Med Chem. 2006 Sep 7;49(18):5411-3.Homobivalent quinazolinimines as novel nanomolar inhibitors of cholinesterases with dirigible selectivity toward butyrylcholinesterase.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.